V. Levine

The Effect of Food on Doravirine Bioavailability: Results from Two Pharmacokinetic Studies in Healthy Subjects

K. Yee, D. Panebianco, Rachael Liu, 2017, Clinical Drug Investigation.

Effect of tildrakizumab (MK‐3222), a high affinity, selective anti‐IL23p19 monoclonal antibody, on cytochrome P450 metabolism in subjects with moderate to severe psoriasis

M. Iwamoto, M. Martinho, P. Shaw, 2018, British journal of clinical pharmacology.

O6 Single doses as low as 0.5 mg of the novel NRTTI MK-8591 suppress HIV for at least 7 days

Sabrina Fox‐Bosetti, D. Hazuda, A. Hüser, 2017 .

Pharmacokinetic Drug‐Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate Mofetil

W. Kraft, J. McCrea, D. Panebianco, 2019, Journal of clinical pharmacology.

No Pharmacokinetic Interaction Between the Hepatitis C Virus Inhibitors Elbasvir/Grazoprevir and Famotidine or Pantoprazole

D. Panebianco, M. Iwamoto, Hwa-ping Feng, 2017, Clinical and translational science.

Evaluation of Pharmacokinetic Drug Interactions of the Direct-Acting Antiviral Agents Elbasvir and Grazoprevir with Pitavastatin, Rosuvastatin, Pravastatin, and Atorvastatin in Healthy Adults

T. Prueksaritanont, J. Butterton, D. Panebianco, 2021, Clinical Drug Investigation.